Community Voice Health

Professor Gordon Rustin, Director of Medical Oncology, Mount Vernon Hospital PDF Print E-mail
User Rating: / 22
Saturday, 13 December 2008 13:56

Gordon Rustin qualified from the Middlesex Hospital, London in 1971. He was appointed Senior Lecturer in Medical Oncology at the Charing Cross Hospital in 1984, but moved full-time to Mount Vernon Hospital to become Director of Medical Oncology in 1995. He was awarded an Honorary Professorship by UCL in 2001 and visiting Professorship by University of Hertfordshire in 2006. He has published widely on management of gynaecological cancers and germ cell tumours’, the use of tumour markers, especially CA 125, and on phase I, II and III trials. His definitions using CA 125 to define response and progression of ovarian carcinoma are internationally known as the “Rustin criteria”.
Since 1990 he has been able to translate laboratory work on vascular targeting into the clinic. As chief investigator of the phase I trials of DMXAA, CA4P and OXI4503 he has developed a unique experience of running trials of vascular disruptive agents (VDAs). He has led the world in introducing functional imaging into determining the activity of VDAs. Because of his large referral practice, he is also able to contribute patients to many other trials. For 5 years until 2008 he was chairman of the ovarian cancer sub group of the NCRI gynaecological clinical studies group.

To delete the advertisment, click the small  x  top right of the video

Part One

Part Two

Comments (1)Add Comment
written by Jo, March 10, 2011
A truely wonderful person, a very good speaker explained the female gyne cancer in simple language for a non medical person..

Write comment
smaller | bigger


Last Updated on Thursday, 09 May 2013 10:14